Exact Sciences
EXAS
#1544
Rank
NZ$19.42 B
Marketcap
$104.95
Share price
5.86%
Change (1 day)
-10.13%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Exact Sciences (EXAS) - Total debt

Total debt on the balance sheet as of September 2024 : NZ$4.87 Billion

According to Exact Sciences's latest financial reports the company's total debt is NZ$4.87 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Exact Sciences - Total debt on balance sheet (from 2009 to 2024)

Total debt by year

Year Total debt Change
2023-12-31NZ$4.03 B4.82%
2022-12-31NZ$3.85 B10.51%
2021-12-31NZ$3.48 B7.97%
2020-12-31NZ$3.23 B127.78%
2019-12-31NZ$1.41 B38%
2018-12-31NZ$1.02 B16295.59%
2017-12-31NZ$6.26 M-20.97%
2016-12-31NZ$7.92 M-9.78%
2015-12-31NZ$8.78 M131.58%
2014-12-31NZ$3.79 M-28.56%
2013-12-31NZ$5.31 M113.83%
2012-12-31NZ$2.48 M93.92%
2011-12-31NZ$1.28 M-1.15%
2010-12-31NZ$1.29 M-52.64%
2009-12-31NZ$2.73 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
NZ$0.25 B-94.81%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$34.79 M-99.29%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$20.47 M-99.58%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$44.98 B 823.03%๐Ÿ‡ซ๐Ÿ‡ท France